![(2R,3S)-(-)-3,4-Dihydro-3-(i-propyl)-2-phenyl-2H-pyrimido[2,1-b]benzothiazole, min. 98% HyperBTM,(2S,3R)-3,4-二氢-3-异丙基-2-苯基-2H-嘧啶并[2,1-b]苯并噻唑 , min. 98%](https://static.jkchemical.com/Structure/182/1822215.png)
(2S,3R)-3,4-二氢-3-异丙基-2-苯基-2H-嘧啶并[2,1-b]苯并噻唑 , min. 98%
(2R,3S)-(-)-3,4-Dihydro-3-(i-propyl)-2-phenyl-2H-pyrimido[2,1-b]benzothiazole, min. 98% HyperBTM
分子式: C₁₉H₂₀N₂S
分子量: 308.44
纯度: min. 98%
| 包装 | 库存 | 价格 | |
|---|---|---|---|
暂无数据 | |||
推荐产品
基本信息
安全信息
化学和物理性质
产品描述
Technical Notes:
1. Isothiourea-mediated intermolecular MichaeI addition-lactonisation.
2.Isothiourea-mediated, asymmetric, Michael-lactonisation of CF3 - enones.
3.a-Functioalisation of 3-alkenoic acids.
4.Isothiourea-catalyzed a-amination of carboxylic acids.
5.Isothiourea-catalyzed O- to C- carboxyl transfer of furanyl carbonates.
6.Isothiourea-catalyzed kinetic resolution of secondary alcohols.
7.Isothiourea-catalyzed a-amination of carboxylic acidswith N-aryl-N-aroyldiazene.
